As the required regulatory authorisations in France and abroad have been granted, Evolem has transferred today its majority stake in APRIL to Andromeda Investissements, a holding c
The APRIL group announces that the publication of its sales for the first quarter of 2019 will take place on Wednesday 24 April 2019, after market close.
On 28 October 2015, the Extraordinary General Meeting authorised the Board of Directors of APRIL to grant bonus shares for a period of 38 months.
As part of the upcoming discussions on financing the transfer of the majority block (see press release dated 28 January 2019), the APRIL group wishes to present the main elements of its outlook for
On 28 January 2019, APRIL, Evolem and CVC Capital Partners announced the signing of an agreement for the transfer of Evolem’s equity stake (65.13% of APRIL’s capital) to Andromeda Investissements,
Following the entry into exclusive negotiations between Evolem and CVC Capital Partners announced on 29 December 2018, the applicable employee consultation procedures were initiated and completed b
Following an analysis of various strategic options regarding the future of its equity interest in APRIL, Evolem, which holds a 65.13% equity stake in APRIL, launched a competitive bidding process r